Green Cross Corporation
KRX:006280.KS
Overview | Financials
Company Name | Green Cross Corporation |
Symbol | 006280.KS |
Currency | KRW |
Price | 156,800 |
Market Cap | 1,789,580,352,000 |
Dividend Yield | 1.32% |
52-week-range | 93,000 - 177,500 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Il-Sup Huh Ph.D. |
Website | https://www.globalgreencross.com |
An error occurred while fetching data.
About Green Cross Corporation
Green Cross Corporation, a biopharmaceutical company, develops drugs and vaccines in South Korea. The company provides plasma derivatives, including albumin, immunoglobulin, and antithrombin; and vaccines for hepatitis-B, Hantavirus hemorrhagic fever, influenza, flu, and varicella. It also offers prescription drugs for the bleeding symptom control and hemostasis for persons with hemophilia
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD